Regeneron Pharmaceutical (NASDAQ:REGN) fell 2% after a court rejected its request for a temporary injunction blocking sales of its generic Eylea by Amgen (AMGN). Amgen ticked higher by 0.4% ...

SUSSEX, Wis. – Quad/Graphics, Inc. (NYSE: NYSE:QUAD), a global marketing experience company, has agreed to sell most of its European business to Capmont GmbH, a German investment firm, for ...

SUSSEX, Wis. – Quad/Graphics, Inc. (NYSE: NYSE:QUAD), a global marketing experience company, has agreed to sell most of its European business to Capmont GmbH, a German investment firm ...

Quad/Graphics (QUAD) has entered into a definitive agreement to sell the majority of its European operations for EUR41M – approximately $45M – to Germany-based entrepreneurial private capital ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shareholders might be concerned after seeing the share price drop 15% in the last month. But that scarcely detracts from the really solid long term ...

Regeneron Pharmaceuticals, Inc. has a 52 week low of $769.19 and a 52 week high of $1,211.20. The company has a debt-to-equity ratio of 0.10, a quick ratio of 4.62 and a current ratio of 5.44.

Former President Rodrigo Duterte has been invited anew to the House of Representatives quad committee’s October 22 hearing on his administration’s war on drugs. He was invited to “provide ...

The sole survivor in a horror head-on crash which killed four people in the state’s central west late last month has fronted court. Jack Bowd was the sole survivor in the collision on the Newell ...

A person has received critical injuries in a quad bike crash in Northland today. The crash occurred at about 12.15pm off State Highway 1 in Mangamuka in the Far North. A police spokesperson said ...

MANILA, Philippines — The House of Representatives' quad committee invited former president Rodrigo Duterte to its hearing on Tuesday, October 22, as it continues to investigate alleged extrajudicial ...

The closing ceremony of Malabar 2024, held on 18 October in Visakhapatnam, marked the conclusion of another significant chapter in the growing maritime collaboration between the Quad nations ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) data for EYLEA HD (aflibercept) Injection 8 mg from an extension study of the Phase 3 PHOTON trial in ...